When and where
Starts: Thursday, 05 February 2026 - 08:00 (in 0 minutes)
Location:
Xtalks, Toronto, Canada
This event was automatically imported. Click the Source link below to double check the Start time and Location.
Event description
Developing in vivo CAR T-cell therapies requires reliable approaches for transient, controlled CAR expression and targeted mRNA delivery to immune cells. This webinar will examine the transformative role of mRNA and lipid nanoparticle (LNP) technologies in advancing in vivo CAR T-cell therapy, including practical considerations for platform selection and optimization.
The featured speakers will explore the foundational principles of mRNA-based CAR T development, focusing on how mRNA enables transient yet precise expression of therapeutic CAR constructs. Additionally, they will discuss the critical role of LNPs in ensuring efficient and targeted delivery of mRNA to immune cells in vivo.
The webinar will also highlight how end-to-end capabilities across mRNA synthesis, LNP formulation development and analytical testing can support optimization for in vivo CAR T applications, with examples of common development challenges and decision points. Attendees will gain valuable insights into the latest innovations in mRNA and LNP technology and how they are shaping the future of CAR T-cell therapy.
Register for this webinar to learn how LNP technology can support in vivo CAR-T development through effective mRNA delivery and analytical readiness.
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 251
- Comments 0